The North America Brain PET-MRI Systems Market would witness market growth of 7.2% CAGR during the forecast period (2020-2026). Brain PET-MRI frameworks have created new opportunities in multiparametric neuroimaging and at the same time observing the physiological and biochemical cycles of the brain. Hence, the establishment of devices in different clinical settings is expanding. According to an article by NCBI, by March 2017, roughly 30 PET-MRI scanners were introduced in the U.S. Furthermore, organizations are conducting studies to comprehend the adequacy of MRI-PET scanners on animals and humans.
In oncology, the basis for prognostic consideration is formed by staging that directly impacts patient care by deciding the therapeutic methodology. After the successful introduction of PET/CT, the quest for proper PET/MRI instrumentation as another bimodal imaging device was heightened.
Hospitals held the highest share of revenue in 2019 predominantly because of an expanding number of neurological disorders. Around, 500,000 instances of multiple sclerosis, brain tumor, and amyotrophic lateral sclerosis are diagnosed every year. This expansion in neurological cases is increasing the demand for its diagnosis. Consequently, hospitals are introducing brain PET-MRI frameworks regularly to upgrade the diagnosis of neurological disorders. In July 2018, the PET-MRI scanner was introduced at Toronto General Hospital for the identification of cancer, heart disorders, and neurological disorders.
The prominence in the worldwide burden of disease is caused by both the growing number of people affected by neurological disorders and the longevity of affected people living with disability. The growth in numbers of people with such disease would place a heavy burden on societies and their health-care systems and these reasons would drive the growth of brain PET-MRI systems Market in the years to come. Moreover, it is generally accepted that integrated PET/MRI may assume a significant role in the care of children, specifically with cancer, who need to go through repeated diagnostic imaging sessions.
Based on Phase Type, the market is segmented into Pre-clinical and Clinical. Based on End User, the market is segmented into Hospitals, Diagnostic imaging centers and Other End Users. Based on Product, the market is segmented into Helium-free PET/MRI Systems, Traditional PET-MRI System. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Brain PET-MRI Systems Market in North America is expected to register a CAGR of 7.2% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Siemens AG (Siemens Healthineers), Koninklijke Philips N.V., General Electric (GE) Co. (GE Healthcare), Bruker Corporation, Mediso Ltd., MR Solutions Group, Cubresa, Inc. and Aspect Imaging Ltd.
Market Segmentation:
By Phase Type
By End-User
By Product
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
